ArticleAlzheimer's research & therapy2023

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP/PS1 mouse.

Shang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.